Managing Director & Partner
Charles Hendren joined Boston Consulting Group's New York office in 2011 and transferred to Stockholm in 2013. He is a core member of the Principal Investors & Private Equity (PIPE) practice, focusing on health care and technology.
Charles has expertise in transaction services, portfolio acceleration, corporate finance and strategy, and digital. He also spent one year as an Ambassador to the Strategy practice working on business model innovation (BMI). With his private equity clients, Charles works on transactions and portfolio value acceleration. Within the health care industry, his expertise includes medtech, specialty pharma, pharma services, life science tools and diagnostics, and health care technology.
The medtech industry is poised for strong growth but faces challenges too. For private equity investors, making sense of the market requires understanding the range of investment themes.
If the last decade was a golden age for PE, the next one could be more gilded. Funds have the potential to deliver exponential growth—provided firms make the needed strategic and operational changes.
Stakeholders from a variety of industries can position themselves to tap the potential of mobile health by developing well-designed, collaborative business models.
When traditional growth levers—such as product extension and pricing—become less effective, it’s time to embrace business model innovation.